高流量鼻氧合在妊娠期快速序贯诱导中维持产妇氧合的功效:一项前瞻性随机临床试验
结果显示HFNO组插管后PaO2和EtO2显著高于SFM组,两组PaCO2均较基线升高但组间无差异,最低饱和度、插管时间、无呼吸时间、pH值及胎儿结局无差异。HFNO是妊娠期剖宫产全麻RSI中安全的氧合方法。
要点
- HFNO组插管后PaO2显著高于SFM组(441.41±46.73 vs 328.71±72.80 mmHg)。
- HFNO组EtO2显著高于SFM组(86.71±4.12% vs 76.94±7.74%)。
- 两组最低饱和度、插管时间、无呼吸时间、pH及胎儿结局无差异。
核心结论
- 与标准面罩相比,HFNO在妊娠期剖宫产全麻快速序贯诱导中插管后提供更高的PaO2和EtO2,且安全性良好。
主要发现
- HFNO组插管后PaO2显著高于SFM组(441.41±46.73 mmHg vs 328.71±72.80 mmHg,P<0.0001)。
- HFNO组开始通气时EtO2显著高于SFM组(86.71±4.12% vs 76.94±7.74%,P<0.0001)。
- 两组插管后PaCO2均较基线显著升高(HFNO组:30.87±2.50 vs 38.28±3.18 mmHg;SFM组:29.82±2.57 vs 38.05±5.76 mmHg,P<0.0001),但组间无差异。
- 两组最低饱和度、插管时间、无呼吸时间、pH值及胎儿结局无差异。
临床怎么用
- 在妊娠期剖宫产全麻快速序贯诱导中,可考虑使用HFNO进行预氧合以改善插管后氧合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High-flow nasal oxygenation (HFNO) for pre-oxygenation in rapid sequence induction (RSI) has only been assessed in volunteer parturients without intubation. OBJECTIVES: To evaluate the efficacy of HFNO in comparison with the conventional facemask for oxygenation during RSI for caesarean section under general anaesthesia. SETTING: Operating room in a tertiary hospital. DESIGN: Prospective randomised, controlled study. PARTICIPANTS: Thirty-four healthy parturients undergoing general anaesthesia for caesarean section. INTERVENTIONS: Parturients were randomly assigned to HFNO or standard facemask (SFM) group. MAIN OUTCOME MEASURES: The primary outcome measure was the PaO2 immediately after intubation. Secondary outcomes included lowest saturation throughout the intubation procedure, end-tidal oxygen concentration (EtO2) on commencing ventilation, blood gas analysis (pH, PaCO2), fetal outcomes and intubation-related adverse events. RESULTS: PaO2 in the HFNO group was significantly higher than that in SFM group (441.41 ± 46.73 mmHg versus 328.71 ± 72.80 mmHg, P < 0.0001). The EtO2 concentration in the HFNO group was higher than that in the SFM group (86.71 ± 4.12% versus 76.94 ± 7.74%, P < 0.0001). Compared to baseline, PaCO2 immediately after intubation also increased significantly in both groups (HFNO group: 30.87 ± 2.50 mmHg versus 38.28 ± 3.18 mmHg; SFM group: 29.82 ± 2.57 mmHg versus 38.05 ± 5.76 mmHg, P < 0.0001), but there was no difference in PaCO2 between the two groups. There was no difference in lowest saturation, intubation times, duration of apnoea, pH value or fetal outcomes. CONCLUSIONS: Compared with SFM, HFNO provided a higher PaO2 and EtO2 immediately after intubation in parturients. HFNO is safe as a method of oxygenation during RSI in parturients undergoing general anaesthesia for caesarean section. TRIAL REGISTRATION: Clinical trial ChiCTR1900023121.
引用
- Zhou S, Zhou Y, Cao X, et al. The efficacy of high flow nasal oxygenation for maintaining maternal oxygenation during rapid sequence induction in pregnancy: A prospective randomised clinical trial. Eur J Anaesthesiol. 2021. PMID: 33259452. doi:10.1097/EJA.0000000000001395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。